Results overview: Found 3 records in 0.01 seconds.
Articles, 3 records found
Articles 3 records found  
1.
26 p, 1021.9 KB Potential business model for a European vaccine R&D infrastructure and its estimated socio-economic impact / Jungbluth, Stefan (European Vaccine Initiative) ; Martin, William (European Vaccine Initiative) ; Slezak, Monika (European Vaccine Initiative) ; Depraetere, Hilde (European Vaccine Initiative) ; Guzman, Carlos A. (Helmholtz Centre for Infection Research) ; Ussi, Anton (EATRIS- European Research Infrastructure for Translational Medicine) ; Morrow, David (EATRIS- European Research Infrastructure for Translational Medicine) ; Van Heuverswyn, Fran (Flanders Vaccine) ; Arnouts, Sven (Ghent University) ; Carrondo, Manuel J. T. (Instituto de Biologia Experimental e Tecnológica) ; Olesen, Ole (European Vaccine Initiative) ; Ottenhoff, Tom H.M. (Leiden University Medical Center) ; Dockrell, H. M. (London School of Hygiene & Tropical Medicine) ; Ho, Mei Mei (Medicines and Healthcare products Regulatory Agency) ; Dobly, Alexandre (Sciensano) ; Christensen, Dennis (Statens Serum Institut) ; Segalés Coma, Joaquim (Unitat mixta d'investigació IRTA-UAB en Sanitat Animal. Centre de Recerca en Sanitat Animal) ; Laurent, Fabrice (Université François Rabelais de Tours) ; Lantier, Frédéric (Université François Rabelais de Tours) ; Stockhofe-Zurwieden, Norbert (Wageningen Bioveterinary Research) ; Morelli, Francesca (CIRMMP) ; Langermans, Jan A.M. (Biomedical Primate Research Centre) ; Verreck, Frank A.W. (Biomedical Primate Research Centre) ; Le Grand, Roger (Université Paris-Saclay) ; Sloots, Arjen (Intravacc) ; Medaglini, Donata (University of Siena) ; Lawrenz, Maria (Vaccine Formulation Institute) ; Collin, Nicolas (Vaccine Formulation Institute)
Research infrastructures are facilities or resources that have proven fundamental for supporting scientific research and innovation. However, they are also known to be very expensive in their establishment, operation and maintenance. [...]
2023 - 10.12688/f1000research.141399.1
F1000Research, Vol. 12 (october 2023)  
2.
13 p, 1.6 MB Immunogenicity of 60 novel latency-related antigens of Mycobacterium tuberculosis / Serra-Vidal, Mᵃdel Mar (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Latorre, Irene (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Franken, Kees L. C. M. (Department of Immunohematology and Blood Transfusion/Department of Infectious Diseases, Leiden University Medical Center) ; Díaz, Jéssica (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; De Souza Galvão, Maria Luiza (Hospital Universitari Vall d'Hebron) ; Casas, Irma (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Maldonado, José (Serveis Clínics (Barcelona)) ; Milà, Celia (Hospital Universitari Vall d'Hebron) ; Solsona, Jordi (Hospital Universitari Vall d'Hebron) ; Jimenez-Fuentes, M. Ángeles (Hospital Universitari Vall d'Hebron) ; Altet, Neus (Hospital Universitari Vall d'Hebron) ; Lacoma, Alicia (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Ruiz-Manzano, Juan (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Ausina, Vicente (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Prat i Aymerich, Cristina (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Ottenhoff, Tom H. M. (Department of Immunohematology and Blood Transfusion/Department of Infectious Diseases, Leiden University Medical Center) ; Domínguez, José (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
The aim of our work here was to evaluate the immunogenicity of 60 mycobacterial antigens, some of which have not been previously assessed, notably a novel series of in vivo -expressed Mycobacterium tuberculosis (IVE-TB) antigens. [...]
2014 - 10.3389/fmicb.2014.00517
Frontiers in microbiology, Vol. 5 (october 2014)  
3.
1.5 MB Cell-Mediated Immune Responses to in vivo -Expressed and Stage-Specific Mycobacterium tuberculosis Antigens in Latent and Active Tuberculosis Across Different Age Groups / Coppola, Mariateresa (Leiden University Medical Center) ; Villar-Hernández, Raquel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; van Meijgaarden, Krista E. (Leiden University Medical Center) ; Latorre, Irene (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Muriel-Moreno, Beatriz (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; García-García, Esther (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Franken, Kees L. M. C. (Leiden University Medical Center) ; Prat i Aymerich, Cristina (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Stojanovic, Zoran (Universitat Autònoma de Barcelona. Departament de Medicina) ; De Souza Galvão, Maria Luiza (Hospital Universitari Vall d'Hebron) ; Millet, Joan-Pau (CIBER de Epidemiología y Salud Pública (CIBEREESP)) ; Sabriá, Josefina (Hospital de Sant Joan Despí Moisès Broggi) ; Sánchez-Montalva, Adrián (Hospital Universitari Vall d'Hebron) ; Noguera-Julian, Antoni (Institut de Recerca Sant Joan de Déu) ; Geluk, Annemieke (Leiden University Medical Center) ; Domínguez, José (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Ottenhoff, Tom H. M. (Leiden University Medical Center)
A quarter of the global human population is estimated to be latently infected by Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB). TB remains the global leading cause of death by a single pathogen and ranks among the top-10 causes of overall global mortality. [...]
2020 - 10.3389/fimmu.2020.00103
Frontiers in immunology, Vol. 11 (february 2020)  

See also: similar author names
2 Ottenhoff, Tom H. M.
2 Ottenhoff, Tom H. M.
1 Ottenhoff, Tom H.M.
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.